Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
3,225,000 shares of common stock will be purchased at $1.20 per share in a registered direct offering.
The gross proceeds are expected to be approximately $3.9 million.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million.
Closing Date
Expected to be on August 15, 2025.
- The offering is made through an effective shelf registration statement on Form S-3 filed with the SEC.
- Maxim Group LLC is the sole placement agent for the offering.
Scienture Holdings is focused on providing enhanced value to patients, physicians, and caregivers through novel specialty products. The successful offering will support the company in its mission.